Home LiteratureArticle Details
PMID: 9573230 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Particle size determinants in the human immunodeficiency virus type 1 Gag protein.

Journal of virology ·Vol. 72 ·No. 6 ·1998-06-00 ·Pages 4667-77

Garnier L, Ratner L, Rovinski B, Cao SX, Wills JW

Abstract

The retroviral Gag protein plays the central role in the assembly process and can form membrane-enclosed, virus-like particles in the absence of any other viral products. These particles are similar to authentic virions in density and size. Three small domains of the human immunodeficiency virus type 1 (HIV-1) Gag protein have been previously identified as being important for budding. Regions that lie outside these domains can be deleted without any effect on particle release or density. However, the regions of Gag that control the size of HIV-1 particles are less well understood. In the case of Rous sarcoma virus (RSV), the size determinant maps to the CA (capsid) and adjacent spacer sequences within Gag, but systematic mapping of the HIV Gag protein has not been reported. To locate the size determinants of HIV-1, we analyzed a large collection of Gag mutants. To our surprise, all mutants with defects in the MA (matrix), CA, and the N-terminal part of NC (nucleocapsid) sequences produced dense particles of normal size, suggesting that oncoviruses (RSV) and lentiviruses (HIV-1) have different size-controlling elements. The most important region found to be critical for determining HIV-1 particle size is the p6 sequence. Particles lacking all or small parts of p6 were uniform in size distribution but very large as measured by rate zonal gradients. Further evidence for this novel function of p6 was obtained by placing this sequence at the C terminus of RSV CA mutants that produce heterogeneously sized particles. We found that the RSV-p6 chimeras produced normally sized particles. Thus, we present evidence that the entire p6 sequence plays a role in determining the size of a retroviral particle.

MeSH Terms
HIV Core Protein p24/chemistry,physiology HIV-1/physiology Humans Sequence Deletion Virion/physiology Virus Assembly/genetics
Chemicals
HIV Core Protein p24
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Garnier L
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
Ratner L
Rovinski B
Cao S X
Wills J W
References (52)
52 references, click to expand
  1. Incorporation of chimeric gag protein into retroviral particles.
    J Virol. 1990 Sep;64(9):4169-79 PMID: 2166812
  2. Genetic determinants of Rous sarcoma virus particle size.
    J Virol. 1998 Jan;72(1):564-77 PMID: 9420260
  3. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.
    J Virol. 1991 Jul;65(7):3804-12 PMID: 1710290
  4. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells.
    Virology. 1991 Sep;184(1):417-22 PMID: 1871977
  5. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
    J Gen Virol. 1991 Oct;72 ( Pt 10):2509-17 PMID: 1919528
  6. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.
    J Virol. 1991 Nov;65(11):6205-17 PMID: 1717718
  7. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.
    J Virol. 1992 Apr;66(4):1856-65 PMID: 1548743
  8. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
    J Virol. 1992 Aug;66(8):4966-71 PMID: 1629961
  9. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
    J Virol. 1992 Dec;66(12):7176-82 PMID: 1433510
  10. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation.
    J Gen Virol. 1992 Dec;73 ( Pt 12):3079-86 PMID: 1469349
  11. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Virology. 1993 Feb;192(2):605-17 PMID: 8421902
  12. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Virology. 1993 Apr;193(2):661-71 PMID: 7681610
  13. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.
    J Virol. 1993 Jul;67(7):4264-73 PMID: 7685414
  14. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9 PMID: 7687060
  15. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.
    J Virol. 1993 Sep;67(9):5550-61 PMID: 8394460
  16. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
    J Virol. 1993 Oct;67(10):6159-69 PMID: 8371356
  17. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
    J Virol. 1993 Nov;67(11):6487-98 PMID: 8411352
  18. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.
    Nature. 1993 Oct 14;365(6447):666-9 PMID: 8105392
  19. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
    J Virol. 1994 Jan;68(1):111-22 PMID: 8254720
  20. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1994 Mar;68(3):1689-96 PMID: 8107229
  21. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
    J Virol. 1994 Apr;68(4):2556-69 PMID: 8139035
  22. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    J Virol. 1994 May;68(5):3232-42 PMID: 8151785
  23. An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
    J Virol. 1994 Oct;68(10):6605-18 PMID: 8083996
  24. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.
    J Virol. 1994 Oct;68(10):6782-6 PMID: 8084015
  25. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1.
    J Gen Virol. 1994 Nov;75 ( Pt 11):2985-97 PMID: 7964608
  26. Functional domains of the capsid protein of human immunodeficiency virus type 1.
    J Virol. 1994 Dec;68(12):8180-7 PMID: 7966609
  27. Biological techniques for avian sarcoma viruses.
    Methods Enzymol. 1979;58:379-93 PMID: 218076
  28. An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.
    Nature. 1985 Mar 28-Apr 3;314(6009):374-7 PMID: 3920530
  29. Active human immunodeficiency virus protease is required for viral infectivity.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90 PMID: 3290901
  30. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
    Proc Natl Acad Sci U S A. 1988 Sep;85(18):6944-8 PMID: 3413127
  31. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence.
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8420-4 PMID: 3141927
  32. A nucleoprotein complex mediates the integration of retroviral DNA.
    Genes Dev. 1989 Apr;3(4):469-78 PMID: 2721960
  33. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.
    J Virol. 1989 Jun;63(6):2550-6 PMID: 2657099
  34. Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.
    J Virol. 1989 Oct;63(10):4331-43 PMID: 2550669
  35. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
    Cell. 1989 Oct 6;59(1):103-12 PMID: 2676191
  36. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):8964-7 PMID: 2479031
  37. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
    J Virol. 1990 May;64(5):1920-6 PMID: 2109098
  38. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
    J Virol. 1995 Feb;69(2):642-50 PMID: 7815527
  39. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    J Virol. 1995 May;69(5):2759-64 PMID: 7707498
  40. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  41. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
    J Virol. 1995 Sep;69(9):5455-60 PMID: 7636991
  42. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7819-23 PMID: 7644498
  43. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.
    J Virol. 1995 Oct;69(10):6106-14 PMID: 7666514
  44. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    J Virol. 1995 Oct;69(10):6487-97 PMID: 7666550
  45. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    J Virol. 1995 Nov;69(11):6810-8 PMID: 7474093
  46. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    J Virol. 1995 Nov;69(11):6873-9 PMID: 7474102
  47. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein.
    J Virol. 1996 Feb;70(2):1016-26 PMID: 8551559
  48. WW domains and retrovirus budding.
    Nature. 1996 Jun 27;381(6585):744-5 PMID: 8657277
  49. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
    J Virol. 1996 Dec;70(12):8645-52 PMID: 8970990
  50. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.
    J Virol. 1997 Mar;71(3):2083-91 PMID: 9032340
  51. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle.
    Curr Biol. 1997 Oct 1;7(10):729-38 PMID: 9368755
  52. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 PMID: 2014240
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-06-00
Pages
4667-77
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC109988
Subset
IM
Grants
NIAID NIH HHS · AI36071 · United States
NCI NIH HHS · CA47482 · United States
NCI NIH HHS · R01 CA047482 · United States
NCI NIH HHS · R37 CA047482 · United States
NIAID NIH HHS · AI34736 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]